The role of blood group antigens in malignant progression, apoptosis resistance, and metastatic behavior

Transfusion Medicine Reviews

Volumn 14, Issue 4, 2000, Pages 326-350

  Glinsky, Gennadi V ^a   Ivanova, Anna B ^a   Welsh, John ^a   McClelland, Michael ^a  

^a SIDNEY KIMMEL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN; CARBOHYDRATE ANTIGEN; COMPLEMENTARY DNA;

ANTIGEN EXPRESSION; ANTIGEN FUNCTION; APOPTOSIS; BLOOD GROUP; CANCER CELL; CANCER GROWTH; CARCINOGENESIS; CELL SURVIVAL; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; METASTASIS; NONHUMAN; PHENOTYPE; REVIEW;

EID: 0033787471     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1053/tmrv.2000.16230     Document Type: Article

References (222)

1. Blood group ABH and Ia antigens of human erythrocytes: Chemistry, polymorphism and their developmental change
2. Genetics of ABO, H, Lewis, X and related antigens
3. ABH and related histo-blood group antigens: Immunochemical differences in carrier isotypes and their distribution
4. The blood group antigen (BGA)-related glycoepitopes: A key structural determinant in immunogenesis and cancer pathogenesis
5. The blood group antigen related glycoepitopes: Key structural determinants in immunogenesis and AIDS pathogenesis
6. Glycodeterminants of melanoma cell adhesion: A model for anti-metastatic drug design
7. Antigen presentation, aberrant glycosylation and tumor progression
8. Apoptosis and metastasis: A superior resistance of metastatic cancer cells to the programmed cell death
9. Apoptosis and metastasis: Increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms
10. Apoptosis in metastatic cancer cells
11. Anti-adhesion cancer therapy
12. Philip Levine Award Lecture: Blood group glycolipid antigens and their modification as human cancer antigens
13. Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens
14. Carbohydrate antigens in human cancer
15. Cell adhesion and metastasis: Is the site specificity of cancer metastasis determined by leukocite-endothelial cell recognition and adhesion?
16. T and Tn, general carcinoma autoantigens
17. Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: A functional predictor of aggressiveness
18. Immunohistochemical localization of T-antigen-like substance in benign hyperplasia and adenocarcinoma of the prostate
19. T antigen expression in benign hyperplasia and adenocarcinoma of the prostate
20. Expression of Tn, sialosyl-Tn, and T antigens in human colon cancer
21. Sialosyl-Tn: A novel mucin antigen associated with prognosis in colorectal cancer patients
22. Serum sialyl-Tn antigen levels in patients with digestive cancers
23. Monoclonal antibodies against partially deglycosylated colon cancer mucin that recognize Tn antigen
24. Sialyl-Tn antigen expression occurs early during human mammary carcinogenesis and is associated with high nuclear grade and aneuploidy
25. Mucins secreted by cell lines derived from colorectal mucinous carcinoma and adenocarcinoma
26. Coexpression of cancer-associated carbohydrate antigens, Tn and sialyl Tn
27. Use of sialylated or sulfated derivatives and acrylamide copolymers of Ga1 beta 1,3Ga1NAc alpha- and Ga1NAc alpha- to determine the specificities of blood group T- and Tn-specific lectins and the copolymers to measure anti-T and anti-Tn antibody levels in cancer patients
28. TAG-72 expression in primary, metastatic and hormonally treated prostate cancer as defined by monoclonal antibody CC49
29. Simple mucin-type carbohydrate antigens (T, sialosyl-T, Tn and sialosyl-Tn) in breast carcinogenesis
30. Expression of sialyl-Tn in fine-needle aspirates from mammographically detected breast lesions: A marker of malignancy?
31. T/Tn pancarcinoma autoantigens: Fundamental, diagnostic, and prognostic aspects
32. Expression of sialyl-Tn in breast cancer: Correlation with prognostic parameters
33. Distinct subpopulations of carcinoma-associated MUC1 mucins as detected by the monoclonal antibody 9H8 and antibodies against the sialyl-Lewis a and sialyl-Lewis x epitopes in the circulation of breast-cancer patients
34. The prognostic significance of sialyl-Tn antigen in women treated with breast carcinoma treated with adjuvant chemotherapy
35. Immunohistochemical detection of sialosyl-Tn antigen in carcinoma of the prostate
36. Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens
37. Enzymatic basis for sialyl-Tn expression in human colon cancer cells
38. Expression of mucin genes and carbohydrate epitopes in 19 human colon carcinoma cell lines
39. Sialyl-Tn antigen as a marker of colon cancer risk in ulcerative colitis: Relation to dysplasia and DNA aneuploidy
40. Tumor-associated sialylated antigens are constitutively expressed in normal human colonic mucosa
41. Different modes of sialyl-Tn expression during malignant transformation of human colonic mucosa
42. Expression of sialyl-Tn, Tn and T antigens in primary liver cancer
43. Expression of the antigen detected by the monoclonal antibody Ca 19.9 in human breast tissues
44. Oncofetal expression of Lex carbohydrate antigens in human colonic adenocarcinomas: Regulation through type 2 core chain synthesis rather than fucosylation
45. Glycolipids of metastatic tissue in liver from colon cancer: Appearance of sialylated Le(x) and Le(x) lipids
46. Sialyl Lewis(x)-I (SLX) as a tumor-associated carbohydrate antigen in sera in patients with gastric and colorectal cancer: Evaluation according to clinico-pathological factors
47. Mosaicism in the expression of tumor-associated carbohydrate antigens in human colonic and gastric cancers
48. Increased expression of sialyl-dimeric LeX antigen in liver metastases of human colorectal carcinoma
49. Metastatic potential of colon carcinoma: Expression of ABO/Lewis-related antigens
50. Sialyl-dimeric Lewis-X antigen expressed on mucin-like glycoproteins in colorectal cancer metastases
51. Sialyl Lewis(x) antigen as defined by monoclonal antibody AM-3 is a marker of dysplasia in the colonic adenoma-carcinoma sequence
52. Increased expression of sialyl Lewis X antigen correlates with poor survival in patients with colorectal carcinoma: Clinicopathological and immunohistochemical study
53. Clinical value of carbohydrate antigens, sialyl Lewis-x and sialyl Lewis-a in gastrointestinal cancer
54. Involvement of carbohydrate antigen sialyl Lewis(x) in colorectal cancer metastasis
55. Biosynthesis in vitro of SA-Lex and SA-diLex by alpha 1 - 3 fucosyltransferases from colon carcinoma cells and embryonic brain tissues
56. Altered glycosylation of the MUC-1 protein core contributes to the colon carcinoma-associated increase of mucin-bound sialyl-Lewis(x) expression
57. Characterization of the major sialyl-Lex-positive mucins present in colon, colon carcinoma, and sera of patients with colorectal cancer
58. Fucosyltransferase III and sialyl-Le(x) expression correlate in cultured colon carcinoma cells but not in colon carcinoma tissue
59. Expression of Lewis(x) sugar structure in the liver metastasis of mouse colon carcinoma (colon 26) cells
60. Fucosyltransferase-producing sialyl Le(a) and sialyl Le(x) carbohydrate antigen in benign and malignant gastrointestinal mucosa
61. Expression of E-selectin on endothelial cells of small veins in human colorectal cancer
62. Up-regulation of the oligosaccharide sialyl Lewis X: A new prognostic parameter in metastatic prostate cancer
63. Increased expression of sialyl Lewis A and sialyl Lewis X in liver metastases of human colorectal carcinoma
64. Sialyl-Lewis(x) and related carbohydrate antigens in the prostate
65. Structures, synthesis and functions of sialyl Le(a)/sialyl Le(x) antigens
66. Human T-cell leukemia virus-1 encoded Tax protein transactivates alpha-1,3-fucosultransferase Fuc-TVII, which synthesizes sialyl Lewis X, a selectin ligand expressed on adult T-cell leukemia cells
67. E-selectin expression in serum and tissue correlates with distant metastasis of colorectal cancer
68. Cancer cell morphology at the invasive front and expression of cell adhesion-related carbohydrate in the primary lesion of patients with colorectal carcinoma with liver metastasis
69. Prognostic factors of colorectal cancer concerning metastases
70. Clinical significance of combined immunohistochemical detection of CD44v and sialyl LeX expression for colorectal cancer patients undergoing curative resection
71. Expression of nm23-H1 gene and sialyl Lewis X antigen in breast cancer
72. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis
73. A flow cytometric analysis of the expression of adhesion molecules on human renal cell carcinoma cells with different metastatic potential
74. Low O-acetylation of sialyl-Le(x) contributes to its overexpression in colon carcinoma metastases
75. Alpha-2,3-sialyltransferase type 3N and alpha-1,3-fucosyltransferase type VII are related to sialyl Lewis(x) synthesis and patient survival from lung carcinoma
76. Increased level of circulating adhesion molecules in the sera of breast cancer patients with distant metastases
77. Gene expression of fucosyl- and sialyl-transferases which synthesize sialyl Lewis X, the carbohydrate ligands for E-selectins, in human breast cancer
78. Endothelial and epithelial expression of sialyl Lewis(x) and sialyl Lewis(a) in lesions of breast carcinoma
79. Prognostic factors in patients with metastatic (stage D2) prostate cancer: Experience from the Scandinavian Cancer Group Study-2
80. Altered mRNA expression of specific molecular species of fucosyl- and sialyl-transferases in human colorectal cancer tissues
81. Sialyl-Lewis-X, Gleason grade and stage in non-metastatic human prostate cancer
82. Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer
83. Serum sialyl Lewis X-I antigen levels in non-small cell lung cancer: Correlation with distant metastasis and survival
84. Correlation of prognosis of breast cancer patients and expression of LeY which acts as a cofactor of tumor procoagulant
85. Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression
86. FC-2.15, a monoclonal antibody active against human breast cancer, specifically recognizes Lewis(x) hapten
87. Immunohistochemical expression of the sialyl Lewis X antigen on gastric cancer cells correlates with the presence of liver metastasis
88. Up-regulation of a set of glycosyltransferase genes in human colorectal cancer
89. Differential expression of beta 1,3galactosyltransferases in human colon cells derived from adenocarcinomas or normal mucosa
90. Carbohydrate chains and hematogenous metastasis: A review
91. Specific detection of sialyl Lewis X determinant carried on the mucin GlcNAcbeta1-6GalNAcalpha core structure as a tumor-associated antigen
92. Immunohistochemical study of sialyl Le(a) and sialyl Le(x) antigen in oral squamous cell carcinoma: The association of sialyl Le(a) expression with the metastatic potential
93. Critical increment of Lewis blood group antigen in serum by cancer found by photodermal immunoassay
94. Expression of mucin (MUCI) in esophageal squamous cell carcinoma: Its relationship with prognosis
95. Sialyl Lewis X expression in vascular permeating lesions as a factor for predicting colorectal cancer metastasis
96. Up-regulation of Lewis enzyme (Fuc-TIII) and plasma-type alpha1,3fucosyltransferase (Fuc-TVI) expression determines the augmented expression of sialyl Lewis x antigen in non-small cell lung cancer
97. Relation between the serum E-selectin level and the survival rate of patients with resected non-small cell lung cancers
98. Recognition by ELAM-1 of the sialyl-LeX determinant on myeloid and tumor cells
99. Human colon carcinoma cells with increased invasive capacity obtained by selection for sialyl-dimeric LeX antigen
100. Metastatic behavior and cell surface properties of HT-29 human colon carcinoma variant cells selected for their differential expression of sialyl-dimeric Le(x)-antigen
101. Selectins induced by interleukin-1beta on the human liver endothelial cells act as ligands for sialyl Lewis X-expressing human colon cancer cell metastasis
102. Recombinant E-selectin-protein mediates tumor cell adhesion via sialyl-Le(a) and sialyl-Le(x)
103. Expression and function of alpha 2,3-sialyl- and alpha 1,3/1,4-fucosyltransferases in colon adenocarcinoma cell lines: Role in synthesis of E-selectin counter-receptors
104. Granule membrane protein 140 (GMP140) binds to carcinomas and carcinoma-derived cell lines
105. Differential glycosylation and cell surface expression of lysosomal membrane glycoproteins in sublines of a human colon cancer exhibiting distinct metastatic potentials
106. Adhesion of human cancer cells to vascular endothelium mediated by a carbohydrate antigen, sialyl Lewis A
107. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium
108. Differential E-selectin-dependent adhesion efficiency in sublines of a human colon cancer with distinct metastatic potential
109. A secreted mucin carrying sialyl-Lewis a from colon carcinoma cells binds to E-selectin and inhibits HL-60 cell adhesion
110. Secreted MUC1 mucins lacking their cytoplasmic part and carrying sialyl-Lewis a and x epitopes from a tumor cell line and sera of colon carcinoma patients can inhibit HL-60 leukocyte adhesion to E-selectin-expressing endothelial cells
111. Comparison of sialyl-Lewis a-carrying CD43 and MUC1 mucins secreted from a colon carcinoma cell line for E-selectin binding and inhibition of leukocyte adhesion
112. A MUC1 mucin secreted from a colon carcinoma cell line inhibits target cell lysis by natural killer cells
113. Role of SPan-1 antigen in adhesion of human colon cancer cells to ascular endothelium
114. A colon carcinoma cell line adheres to P-selectin under flow conditions independent of PSGL-1
115. An E-selectin-IgG chimera supports sialylated moiety dependent adhesion of colon carcinoma cells under fluid flow
116. Expression of leukocyte-associated sialoglycoprotein CD43 by a colon carcinoma cell line
117. Characterization of human colon carcinoma variant cells selected for sialyl Lex carbohydrate antigen: Liver colonization and adhesion to vascular endothelial cells
118. Differential colon cancer cell adhesion to E-, P-, and L-selectin: Role of mucin-type glycoproteins
119. Alpha(1,3)fucosyltransferase expression in E-selectin-mediated rolling of gastrointestinal tumor cells
120. Effect of O-glycosylated mucin on invasion and metastasis of HM7 human colon cancer cells
121. E-selectin: Sialyl Lewis a dependent adhesion of colon cancer cells is inhibited differently by antibodies against E-selectin ligands
122. Colonization of human lung grafts in SCID-hu mice by human colon carcinoma cells
123. Alteration of integrins by heparin-binding EGF-like growth factor in human breast cancer cells
124. Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue
125. Novel glycoproteins inhibiting the binding of colorectal cancer cells to E-selectin
126. Involvement of hepatocyte growth factor in increasing integrin expression on HepG2 cells triggered by adhesion to endothelial cells
127. The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer
128. Alterative expression of the collagenase and adhesion molecules in the highly metastatic clones of human colonic cancer cell lines
129. Comparison of 16 human colon carcinoma cell lines for their expression of sialyl LeX antigens and their E-selectin-dependent adhesion
130. Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer
131. In vitro experimental studies of sialyl Lewis X and sialyl Lewis A on endothelial and carcinoma cells: Crucial glycans on selectin ligands
132. Liver metastasis and adhesion to the sinusoidal endothelium by human colon cancer cells is related to mucin carbohydrate chain length
133. Enhancement of metastatic activity of colon cancer as influenced by expression of cell surface antigens
134. CD24 mediates rolling of breast carcinoma cells on P-selectin
135. Characterization of E-selectin-binding epitopes expressed by skin-homing T cells
136. Role of sialylglycoconjugate(s) in the initial phase of metastasis of liver-metastatic RAW117 lymphoma cells
137. Effect of shear stress and a stable prostaglandin I2 analogue on adhesive interactions of colon cancer cells and endothelial cells
138. High expression of glycosphingolipids involved in procoagulant activity of cancer cells
139. Proposed molecular basis of murine tumor cell-hepatocyte interaction
140. Specific role of T and Tn tumor-associated antigens in adhesion between a human carcinoma cell line and a normal human breast epithelial cell line
141. Inhibition of liver metastases from neuraminidase-treated colon 26 cells by an anti-Thomsen-Friedenreich-specific monoclonal antibody
142. Effects of T antigen specific peptide P-30 on β-galactoside mediated homotypic aggregation and adhesion to endothelium of MDA-MB-435 human breast carcinoma cells
143. E-selectin-dependent adhesion efficiency of colonic carcinoma cells is increased by genetic manipulation of their cell surface lamp-1 expression levels
144. Carbohydrate antigens in carcinoma invasion and metastasis
145. Suppression of sialyl Lewis X expression and E-selectin-mediated cell adhesion in cultured human lymphoid cells by transfection of antisense cDNA of alpha-1,3-fucosyltransferase (Fuc-TVII)
146. Role of sialosyl Lewis(a) in adhesion of colon cancer cells: The antisense RNA approach
147. P-selectin deficiency attenuates tumor growth and metastasis
148. Metastatic potential of human CX-1 colon adenocarcinoma cells is dependent on the expression of sialosyl Le(a) antigen
149. Dual role of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells
150. Expression of human alpha(1,3)fucosyltransferase antisense sequences inhibits selectin-mediated adhesion and liver metastasis of colon carcinoma cells
151. Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells
152. Overexpression of alpha(1,3)-fucosyltransferase VII is sufficient for the acquisition od lung colonization phenotype in human lung adenocarcinoma HAL-24Luc cells
153. Liver colonization by human colon cancer cells is reduced by antisense inhibition of MUC2 mucin synthesis
154. Immunization of breast cancer patients using a synthetic sialyl-Tn glycoconjugate plus Detox adjuvant
155. CD69+ and HLA-DR+ activation antigens on peripheral blood lymphocyte populations in metastatic breast and ovarian cancer patients: Correlations with survival following active specific immunotherapy
156. Immunogenicity of synthetic TF-KLH (keyhole limpet hemocyanin) and sTn-KLH conjugates in colorectal carcinoma patients
157. A randomised phase II study of sialyl-Tn and DETOX-B adjuvant with or without cyclophosphamide pretreatment for the active specific immunotherapy of breast cancer
158. Evidence of a cellular immune response against sialyl-Tn in breast and ovarian cancer patients after high-dose chemotherapy, stem cell rescue, and immunization with Theratope STn-KLH cancer vaccine
159. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl) cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells
160. Tumor-associated glycoantigen, sialyl Lewis(a) as a target for bispecific antibody-directed adoptive tumor immunotherapy
161. Peptide mimicry of adenocarcinoma-associated carbohydrate antigens
162. Towards the development of peptide mimotopes of carbohydrate antigens as cancer vaccines
163. Lymphocyte triggering via L-selectin leads to enhanced galectin-3-mediated binding to dendritic cells
164. Biosynthesis and regulation of Le(x) and SA-Le(x) glycolipids in metastatic human colon carcinoma cells
165. De novo synthesis of type 1 lacto-series glycolipids in human colonic adenocarcinoma cells: Efficient synthesis of the Le(a) antigen and absence of brefeldin A-induced inhibition of its synthesis in Colo 205 cells
166. Alterations of O-glycan biosynthesis in human colon cancer tissues
167. O-glycan biosynthesis in human colorectal adenoma cells during progression to cancer
168. Two different glycosyltransferase defects that result in Ga1NAc alpha-O-peptide (Tn) expression
169. Human colon cancer cell lines permanently expressing alpha 2,6-sialylated sugar chains by transfection with rat beta-galactoside alpha 2,6 sialyltransferase cDNA
170. Genetic evidence for the Lewis enzyme, which synthesizes type-1 Lewis antigens in colon tissue, and intracellular localization of the enzyme
171. Distinct substrate specificity of five human alpha-1,3-fucosyltransferases for in vivo synthesis of the sialyl Lewis X and Lewis X epitopes
172. Cloning, expression, and characterization of a novel UDP-galactose: Beta-N-acetylglucosamine beta1,3-galactosyltransferase (beta3Gal-T5) responsible for synthesis of type 1 chain in colorectal and pancreatic epithelia and tumor cells derived therefrom
173. Altered mRNA expression of glycosyltransferases in human gastric carcinomas
174. Expression of core 2 beta-1,6-N-acetylglucosaminyltransferase in a human pancreatic cancer cell line results in altered expression of MUC1 tumor-associated epitopes
175. Purification and characterization of a membrane-bound and a secreted mucin-type glycoprotein carrying the carcinoma-associated sialyl-Lea epitope on distinct core proteins
176. Post-translational fate of a mucin-like leukocyte sialoglycoprotein (CD43) aberrantly expressed in a colon carcinoma cell line
177. Characterization of mucin-type oligosaccharides with the sialyl-Le(a) structure from human colorectal adenocarcinoma cells
178. Lack of selectin-dependent adhesion in prostate cancer cells expressing sialyl Le(x)
179. Sialyl Tn is a frequently expressed antigen in colorectal cancer: No correlation with patient prognosis
180. Immunohistochemical expression of sialyl Tn, sialyl Lewis a, sialyl Lewis a-b, and sialyl Lewis x in primary tumor and metastatic lymph nodes in human gastric cancer
181. Differences in sialyl-Tn antigen expression between keratoacanthomas and cutaneous squamous cell carcinomas
182. Tumor cell arrest in the microcirculation: Lack of evidence for a leukocyte-like rolling adhesive interaction with vascular endothelium in vivo
183. Human mannose-binding lectin preferentially binds to human colon adenocarcinoma cell lines expressing high amount of Lewis A and Lewis B antigens
184. Preferential adhesion of prostate cancer cells to a human bone marrow endothelial cell line
185. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells
186. Expression of Lamp-1 and Lamp-2 and their interactions with galectin-3 in human tumor cells
187. Carcinoembryonic antigen, a human tumor marker, functions as intercellular adhesion molecule
188. CEA-mediated homotypic aggregation of human colorectal carcinoma cells in a malignant effusion
189. Expression of endogenous galactoside-binding lectin correlates with neoplastic progression in the colon
190. Colon cancer mucin: A new ligand for the b-galactoside-binding protein galectin-3
191. The adhesive specificity of the soluble human lectin, IgE-binding protein, toward lipid-linked oligosaccharides: Presence of the blood group A, B, B-like, and H monosaccharides confers a binding activity to tetrasaccharide (lacto-N-tetraose and lacto-N-neotetraose) backbones
192. Galectins: An evolutionary conserved family of animal lectins with multifunctional properties; A trip from the gene to clinical therapy
193. Galectins: Versatile modulators of cell adhesion, cell proliferation, and cell death
194. Cell cycle arrest and inhibition of anoikis by galectin-3 in human breast epithelial cells
195. Regulation of cell adhesion molecule expression and function associated with neutrophil apoptosis
196. Neutrophil apoptosis is modulated by endothelial transmigration and adhesion molecule engagement
197. Apoptosis in circulating PMN: Increased susceptibility in L-selectin-deficient PMN
198. LeY antigen expression is correlated with apoptosis (programmed cell death)
199. Lewis Y antigen expression and postoperative survival in non-small cell lung cancer
200. Inhibition of colony formation in agarose of metastatic human breast carcinoma and melanoma cells by synthetic glycoamines
201. Inhibition of human breast cancer metastasis in nude mice by synthetic glycoamines
202. Glycoamines: Structural-functional characterization of a new class of human tumor markers
203. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique
204. Critical factors in the biology of human cancer metastasis
205. The nude mouse model for studies of human cancer metastasis
206. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice
207. Metastatic behavior of tumor cells isolated from primary and metastatic human colorectal carcinomas implanted into different sites in nude mice
208. Growth and metastasis of tumor cells isolated from a renal cell carcinoma implanted into different organs of nude mice
209. Novel intrapulmonary model for orthotopic propagation of human lung cancer in athymic nude mice
210. Orthotopic growth and metastasis of human prostate carcinoma in nude mice after transplantation of histologically intact tissue
211. Metastatic model for human prostate cancer using orthotopic implantation in nude mice
212. Development of orthotopic models of metastatic human prostate cancer
213. Surgical orthotopic implantation allows high lung and lymph node metastasis expression of human prostate carcinoma cell line PC-3 in nude mice
214. High-malignancy orthotopic mouse model of human prostate cancer LNCaP
215. A fluorescent orthotopic bone metastasis model of human prostate cancer
216. In vivo selection of highly metastatic cells from surgical specimens of different primary human colon carcinoma implanted in nude mice
217. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice
218. Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice
219. Non-stoichiometric reduced complexity probes for cDNA arrays
220. Expression monitoring by hybridization to high-density oligonucleotide arrays